2. MUELLER C, FLOTTE T R. Clinical gene therapy using recombinant adeno-associated virus vectors[J]. Gene Ther, 2008, 15(11): 858-863.
[2]
1. ？GRIEGER J C, SAMULSKI R J. Adeno-associated virus vectorology, manufacturing, and clinical applications[J]. Methods Enzymol, 2012, 507: 229-254.
[3]
7. HILDINGER M, BALDI L, STETTLER M, et al. High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cells[J]. Biotechnol Lett, 2007, 29(11): 1713-1721.
[4]
3. MINGOZZI F, HIGH K A. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges[J]. Nat Rev Genet, 2011, 12(5): 341-355.
[5]
4. XIAO X, LI J, SAMULSKI R J. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus[J]. J Virol, 1998, 72(3): 2224-2232.
[6]
5. DALBY B, CATES S, HARRIS A, et al. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications[J]. Methods, 2004, 33(2): 95-103.
[7]
6. WALTERS R W, DUAN D, ENGELHARDT J F, et al. Incorporation of adeno-associated virus in a calcium phosphate coprecipitate improves gene transfer to airway epithelia in vitro and in vivo[J]. J Virol, 2000, 74(1): 535-540.
[8]
8. FENG L, GUO M, ZHANG S, et al. Improvement in the suspension-culture production of recombinant adeno-associated virus-LacZ in HEK-293 cells using polyethyleneimine-DNA complexes in combination with hypothermic treatment[J]. Biotechnol Appl Biochem, 2008, 50(Pt 2): 121-132.
[9]
9. GRIMM D, KERN A, RITTNER K, et al. Novel tools for production and purification of recombinant adenoassociated virus vectors[J]. Hum Gene Ther, 1998, 9(18): 2745-2760.
[10]
10. RUDOLPH C, LAUSIER J, NAUNDORF S, et al. In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers[J]. J Gene Med, 2000, 2(4): 269-278.
[11]
11. AKINC A, THOMAS M, KLIBANOV A M, et al. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis[J]. J Gene Med, 2005, 7(5): 657-663.
[12]
12. ZABNER J, FASBENDER AJ, MONINGER T, et al. Cellular and molecular barriers to gene transfer by a cationic lipid[J]. J Biol Chem, 1995, 270(32): 18997-19007.
[13]
13. HUNTER A C. Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity[J]. Adv Drug Deliv Rev, 2006, 58(14): 1523-1531.
[14]
14. MOGHIMI S M, SYMONDS P, MURRAY J C, et al. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy[J]. Mol Ther, 2005, 11(6): 990-995.
